dc.contributor.authorKoh, Phay Chung
dc.date.accessioned2016-11-04T05:04:22Z
dc.date.available2016-11-04T05:04:22Z
dc.date.issued2016
dc.identifier.citationKoh, P. C. (2016, March). Preclinical safety and immunogenicity evaluation of bioactive antimicrobial peptides. Presented at Discover URECA @ NTU poster exhibition and competition, Nanyang Technological University, Singapore.en_US
dc.identifier.urihttp://hdl.handle.net/10220/41624
dc.description.abstractBackground: Bioactive peptides with antimicrobial properties have many potential applications, ranging from food preservation to the treatment of drug-resistant infections. However, some of these peptides may induce unwanted toxicity or immunogenicity. Regulatory agencies, therefore, require rigours safety assessments of all the therapeutic peptides using appropriate biological model systems. Our collaborating group has developed a novel series of AMPs with broad spectrum antimicrobial activities. Aim: To examine possible cytotoxicity and immunogenicity (if any) of the four AMPs (Pep 1, Pep 2, Pep 3, & Pep 4) using cell culture model systems. [2nd Award]en_US
dc.language.isoenen_US
dc.rights© 2016 Author(s).en_US
dc.subjectAntimicrobial peptide
dc.subjectImmunogenicity
dc.titlePreclinical safety and immunogenicity evaluation of bioactive antimicrobial peptidesen_US
dc.typeStudent Research Poster
dc.contributor.schoolLee Kong Chian School of Medicineen_US
dc.contributor.supervisorNavin Kumar Vermaen_US
dc.description.degreeStudent Research Posteren_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record